Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents III: The 2023 Geneva revision
Methodological detailsinternational consensus conference, revision
- International consensus conference
- Revision
Scope
As issued by the authors
Pharmacodynamic studies of NMBAs; review and update of the 1996 Copenhagen and 2005 Stockholm consensus guidelines in view of new monitoring devices (e.g., electromyography, three-dimensional acceleromyography, kinemyography) and novel compounds (e.g., sugammadex)
Original publication
Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents III: The 2023 Geneva revision. Acta Anaesthesiol Scand. Published 22 June 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →